Internal medicine journal
-
Internal medicine journal · May 2021
Health Status and Health Care Trends of Individuals Accessing Australian Aged Care Programs Over a Decade: The Registry of Senior Australians (ROSA) Historical Cohort.
Understanding the health profile, service and medicine use of Australians in the aged care sector will help inform appropriate service provision for our ageing population. ⋯ The health of older Australians accessing aged care programmes has declined while frailty increased, with an increasing use of medicine and worse long-term mortality in some. Funding and care models need to adapt to this changing profile.
-
Internal medicine journal · May 2021
Prevalence of COVID-19 and Seroprevalence to SARS-CoV-2 in a Rheumatologic Patients Population from a Tertiary Referral Clinic in Israel.
It is unclear if the prevalence of COVID-19 in rheumatologic patients is similar to that of the general population. There are no reports of seroprevalence of SARS-CoV-2 in these patients. ⋯ The prevalence of COVID-19 in a population of rheumatologic patients was similar to that of the general population. Mild/asymptomatic cases may be prevalent according to serologic tests. The major risk factor for infection is exposure to a known case of COVID-19, and immunosuppression did not play a role in the risk of infection.
-
Internal medicine journal · May 2021
Glycaemic control across the lifespan in a cohort of New Zealand patients with type 1 diabetes mellitus.
It is well known that tight glycaemic control reduces all-cause mortality and the development of microvascular complications in patients with type 1 diabetes mellitus (T1D), but that effective glycaemic control is difficult to achieve in different age groups. Currently, the state of glycaemic control across the lifespan in patients with T1D in New Zealand is not known. ⋯ Poor glycaemic control in Waikato patients with T1D is likely due to inequities in health care, including reduced access to insulin pump therapy, particularly in Māori and socially deprived populations.
-
Internal medicine journal · May 2021
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vaccination roll out in both countries, representatives from the Haematology Society of Australia and New Zealand and infectious diseases specialists have collaborated on this consensus position statement regarding COVID-19 vaccination in patients with haematological disorders. ⋯ Vaccination should not replace other public health measures in these patients, given that the effectiveness of COVID-19 vaccination, specifically in patients with haematological malignancies, is not known. Given the limited available data, prospective collection of safety and efficacy data of COVID-19 vaccination in this patient group is a priority.
-
Internal medicine journal · May 2021
Association between 5-hydroxytryptamine gene polymorphism rs140700 and primary insomnia in Chinese population.
Primary insomnia is a worldwide problem and it has a considerable negative impact on one's physical and mental health. Studies have shown that non-synonymous Single-nucleotide polymorphisms in 5-hydroxytryptamine (serotonin or 5-HT) are related to primary insomnia. Previous studies have shown that 5-HT polymorphism (rs140700) is related to depression, and insomnia is often accompanied by depression and anxiety. The relationship between this site and primary insomnia is unknown. We speculated that this site may be related to primary insomnia, so we investigated the relationship between rs140700 and primary insomnia. ⋯ The 5-HT gene polymorphism rs140700 may not be a susceptibility locus for primary insomnia in the Chinese population.